Reply to the Letter to the Editor: “Comparison of the Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma”
Author:
Publisher
S. Karger AG
Subject
Oncology,Hepatology
Reference10 articles.
1. Schotten C, Bechmann LP, Manka P, Theysohn J, Dechêne A, El Fouly A, et al. NAFLD-associated comorbidities in advanced stage HCC do not alter the safety and efficacy of yttrium-90 radioembolization. Liver Cancer. 2019 Nov;8(6):491–504.
2. Liang L, Sun LY, Diao YK, Yang T. Comparison of safety and efficacy of yttrium-90 radioembolization for nonalcoholic fatty liver disease-associated and hepatitis B virus-associated hepatocellular carcinoma. Liver Cancer. DOI: 10.1159/000506353.
3. Kuss O, Blettner M, Börgermann J. Propensity score: an alternative method of analyzing treatment effects. Dtsch Arztebl Int. 2016 Sep;113(35-36):597–603.
4. Ali MS, Prieto-Alhambra D, Lopes LC, Ramos D, Bispo N, Ichihara MY, et al. Propensity score methods in health technology assessment: principles, extended applications, and recent advances. Front Pharmacol. 2019 Sep;10:973.
5. King G, Nielsen R. Why propensity scores should not be used for matching. Polit Anal. 2019;27(4):435–54.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3